AAPL341.15+1.65 (+0.49%) ▲|ABBV286.36-2.60 (-0.90%) ▼|ABT99.16-3.29 (-3.21%) ▼|ACN239.63+0.51 (+0.21%) ▲|ADBE256.33-0.40 (-0.16%) ▼|AMAT407.98+3.00 (+0.74%) ▲|AMD542.98+8.24 (+1.54%) ▲|AMGN436.48-2.46 (-0.56%) ▼|AMT179.77-3.79 (-2.06%) ▼|AMZN260.04-2.59 (-0.99%) ▼|AVGO333.80-0.57 (-0.17%) ▼|AXP321.75+3.41 (+1.07%) ▲|BA191.87+1.40 (+0.74%) ▲|BAC50.73+0.09 (+0.18%) ▲|BKNG157.99-5.93 (-3.62%) ▼|BLK1,132.51+3.83 (+0.34%) ▲|BMY61.25-0.44 (-0.71%) ▼|BNY145.28+1.03 (+0.71%) ▲|BRK-B541.72+1.90 (+0.35%) ▲|C122.60+0.09 (+0.07%) ▲|CAT734.01+8.77 (+1.21%) ▲|CL93.58-0.96 (-1.02%) ▼|CMCSA21.80-0.57 (-2.53%) ▼|COF209.72+8.16 (+4.05%) ▲|COP146.24+0.29 (+0.20%) ▲|COST990.15-4.46 (-0.45%) ▼|CRM241.54-0.90 (-0.37%) ▼|CSCO107.36+0.65 (+0.60%) ▲|CVS94.10-0.66 (-0.69%) ▼|CVX226.91+1.20 (+0.53%) ▲|DE628.79-3.41 (-0.54%) ▼|DHR228.90+4.66 (+2.08%) ▲|DIS110.58-1.09 (-0.98%) ▼|DUK121.17-0.16 (-0.13%) ▼|EMR161.89+1.43 (+0.89%) ▲|FDX298.94+0.18 (+0.06%) ▲|GD345.69+1.25 (+0.36%) ▲|GE304.97+5.10 (+1.70%) ▲|GEV921.39+31.06 (+3.49%) ▲|GILD152.75-3.76 (-2.40%) ▼|GM75.77-1.32 (-1.71%) ▼|GOOG327.00-9.40 (-2.79%) ▼|GOOGL331.07-9.21 (-2.71%) ▼|GS891.05+6.24 (+0.70%) ▲|HD313.58-1.53 (-0.48%) ▼|HON214.76+1.44 (+0.67%) ▲|IBM244.12+2.20 (+0.91%) ▲|INTC91.80+0.11 (+0.11%) ▲|INTU333.34-1.96 (-0.58%) ▼|ISRG418.37-19.63 (-4.48%) ▼|JNJ255.38-3.99 (-1.54%) ▼|JPM333.44-1.82 (-0.54%) ▼|KO92.86-0.64 (-0.68%) ▼|LIN500.09-1.80 (-0.36%) ▼|LLY1,266.98-16.68 (-1.30%) ▼|LMT548.71+0.00 (+0.00%) ▲|LOW195.92-1.36 (-0.69%) ▼|LRCX265.10+1.65 (+0.63%) ▲|MA621.11+0.69 (+0.11%) ▲|MCD244.10-2.42 (-0.98%) ▼|MDLZ63.16-0.83 (-1.30%) ▼|MDT93.77-0.87 (-0.91%) ▼|META704.66+10.41 (+1.50%) ▲|MMM170.67-0.70 (-0.41%) ▼|MO74.12-0.53 (-0.70%) ▼|MRK148.65+0.35 (+0.24%) ▲|MS181.69+1.29 (+0.72%) ▲|MSFT529.51-2.36 (-0.44%) ▼|MU904.87+8.80 (+0.98%) ▲|NEE78.56-0.30 (-0.38%) ▼|NFLX65.92-2.77 (-4.03%) ▼|NKE37.57-0.32 (-0.83%) ▼|NOW151.90+2.36 (+1.57%) ▲|NVDA218.12+1.65 (+0.76%) ▲|ORCL129.46-1.68 (-1.28%) ▼|PEP134.35+0.33 (+0.25%) ▲|PFE29.88-0.24 (-0.78%) ▼|PG157.97-1.35 (-0.85%) ▼|PLTR196.90+4.30 (+2.23%) ▲|PM196.25-3.66 (-1.83%) ▼|QCOM176.25+0.54 (+0.31%) ▲|RTX191.35-1.99 (-1.03%) ▼|SBUX98.62-0.75 (-0.75%) ▼|SCHW91.23+0.34 (+0.37%) ▲|SO90.40-0.32 (-0.35%) ▼|SPG205.54-1.46 (-0.70%) ▼|T22.01-1.41 (-6.02%) ▼|TMO690.98+3.61 (+0.53%) ▲|TMUS153.72-4.04 (-2.56%) ▼|TSLA386.41+12.70 (+3.40%) ▲|TXN282.60+4.82 (+1.73%) ▲|UBER68.42-0.52 (-0.75%) ▼|UNH417.07-2.19 (-0.52%) ▼|UNP290.03+2.42 (+0.84%) ▲|UPS99.03+0.51 (+0.51%) ▲|USB59.03-0.06 (-0.10%) ▼|V407.04+0.47 (+0.12%) ▲|VZ43.39-1.16 (-2.59%) ▼|WFC81.86-0.34 (-0.41%) ▼|WMT117.51-0.34 (-0.29%) ▼|XOM177.96+0.10 (+0.06%) ▲|AAPL341.15+1.65 (+0.49%) ▲|ABBV286.36-2.60 (-0.90%) ▼|ABT99.16-3.29 (-3.21%) ▼|ACN239.63+0.51 (+0.21%) ▲|ADBE256.33-0.40 (-0.16%) ▼|AMAT407.98+3.00 (+0.74%) ▲|AMD542.98+8.24 (+1.54%) ▲|AMGN436.48-2.46 (-0.56%) ▼|AMT179.77-3.79 (-2.06%) ▼|AMZN260.04-2.59 (-0.99%) ▼|AVGO333.80-0.57 (-0.17%) ▼|AXP321.75+3.41 (+1.07%) ▲|BA191.87+1.40 (+0.74%) ▲|BAC50.73+0.09 (+0.18%) ▲|BKNG157.99-5.93 (-3.62%) ▼|BLK1,132.51+3.83 (+0.34%) ▲|BMY61.25-0.44 (-0.71%) ▼|BNY145.28+1.03 (+0.71%) ▲|BRK-B541.72+1.90 (+0.35%) ▲|C122.60+0.09 (+0.07%) ▲|CAT734.01+8.77 (+1.21%) ▲|CL93.58-0.96 (-1.02%) ▼|CMCSA21.80-0.57 (-2.53%) ▼|COF209.72+8.16 (+4.05%) ▲|COP146.24+0.29 (+0.20%) ▲|COST990.15-4.46 (-0.45%) ▼|CRM241.54-0.90 (-0.37%) ▼|CSCO107.36+0.65 (+0.60%) ▲|CVS94.10-0.66 (-0.69%) ▼|CVX226.91+1.20 (+0.53%) ▲|DE628.79-3.41 (-0.54%) ▼|DHR228.90+4.66 (+2.08%) ▲|DIS110.58-1.09 (-0.98%) ▼|DUK121.17-0.16 (-0.13%) ▼|EMR161.89+1.43 (+0.89%) ▲|FDX298.94+0.18 (+0.06%) ▲|GD345.69+1.25 (+0.36%) ▲|GE304.97+5.10 (+1.70%) ▲|GEV921.39+31.06 (+3.49%) ▲|GILD152.75-3.76 (-2.40%) ▼|GM75.77-1.32 (-1.71%) ▼|GOOG327.00-9.40 (-2.79%) ▼|GOOGL331.07-9.21 (-2.71%) ▼|GS891.05+6.24 (+0.70%) ▲|HD313.58-1.53 (-0.48%) ▼|HON214.76+1.44 (+0.67%) ▲|IBM244.12+2.20 (+0.91%) ▲|INTC91.80+0.11 (+0.11%) ▲|INTU333.34-1.96 (-0.58%) ▼|ISRG418.37-19.63 (-4.48%) ▼|JNJ255.38-3.99 (-1.54%) ▼|JPM333.44-1.82 (-0.54%) ▼|KO92.86-0.64 (-0.68%) ▼|LIN500.09-1.80 (-0.36%) ▼|LLY1,266.98-16.68 (-1.30%) ▼|LMT548.71+0.00 (+0.00%) ▲|LOW195.92-1.36 (-0.69%) ▼|LRCX265.10+1.65 (+0.63%) ▲|MA621.11+0.69 (+0.11%) ▲|MCD244.10-2.42 (-0.98%) ▼|MDLZ63.16-0.83 (-1.30%) ▼|MDT93.77-0.87 (-0.91%) ▼|META704.66+10.41 (+1.50%) ▲|MMM170.67-0.70 (-0.41%) ▼|MO74.12-0.53 (-0.70%) ▼|MRK148.65+0.35 (+0.24%) ▲|MS181.69+1.29 (+0.72%) ▲|MSFT529.51-2.36 (-0.44%) ▼|MU904.87+8.80 (+0.98%) ▲|NEE78.56-0.30 (-0.38%) ▼|NFLX65.92-2.77 (-4.03%) ▼|NKE37.57-0.32 (-0.83%) ▼|NOW151.90+2.36 (+1.57%) ▲|NVDA218.12+1.65 (+0.76%) ▲|ORCL129.46-1.68 (-1.28%) ▼|PEP134.35+0.33 (+0.25%) ▲|PFE29.88-0.24 (-0.78%) ▼|PG157.97-1.35 (-0.85%) ▼|PLTR196.90+4.30 (+2.23%) ▲|PM196.25-3.66 (-1.83%) ▼|QCOM176.25+0.54 (+0.31%) ▲|RTX191.35-1.99 (-1.03%) ▼|SBUX98.62-0.75 (-0.75%) ▼|SCHW91.23+0.34 (+0.37%) ▲|SO90.40-0.32 (-0.35%) ▼|SPG205.54-1.46 (-0.70%) ▼|T22.01-1.41 (-6.02%) ▼|TMO690.98+3.61 (+0.53%) ▲|TMUS153.72-4.04 (-2.56%) ▼|TSLA386.41+12.70 (+3.40%) ▲|TXN282.60+4.82 (+1.73%) ▲|UBER68.42-0.52 (-0.75%) ▼|UNH417.07-2.19 (-0.52%) ▼|UNP290.03+2.42 (+0.84%) ▲|UPS99.03+0.51 (+0.51%) ▲|USB59.03-0.06 (-0.10%) ▼|V407.04+0.47 (+0.12%) ▲|VZ43.39-1.16 (-2.59%) ▼|WFC81.86-0.34 (-0.41%) ▼|WMT117.51-0.34 (-0.29%) ▼|XOM177.96+0.10 (+0.06%) ▲|
10.7 C
New York
Wednesday, October 21, 2026

Tag: director

newsFORsourcecompanycontentinformation1releasesmarket

Phase 3 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH Through Week 182 in Adults with Hypoparathyroidism

COPENHAGEN, Denmark, June 13, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced Week 182 data from its completed Phase 3 PaTHway Trial showing that long-term treatment with TransCon PTH (palopegteriparatide) demonstrated sustained efficacy and safety in adults with hypoparathyroidism. Over the three-and-a-half-year duration of the trial, TransCon PTH replicated the systemic actions of endogenous PTH, with a balanced, beneficial impact on the main target organ systems – CNS, kidney, small intestine, and bone – as demonstrated by improved quality of life and normalized and stable urine calcium, serum calcium, serum phosphate, and bone mineral density. These benefits were sustained while enabling independence from conventional therapy with active vitamin D and calcium.

Genmab Announces Epcoritamab Monotherapy and Epcoritamab-Based Combination Regimens Demonstrate High Response Rates in Elderly Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

Media Release

COPENHAGEN, Denmark; June 13, 2026

Gala Night of the 28th Shanghai International Film Festival Held in Shanghai

SHANGHAI, June 13, 2026 /PRNewswire/ -- The Gala Night of the 28th Shanghai International Film Festival (SIFF) was held in Shanghai today, bringing together...

MGI Tech Showcases Expanding Genomics Ecosystem at ESHG 2026 with New IVD Partnering Program and OEM Collaborations

GOTHENBURG, Sweden, June 13, 2026 /PRNewswire/ -- MGI Tech Co., Ltd. (MGI), a company committed to developing core tools and technologies that drive innovation...

/R E P E A T — MEDIA INVITATION – Over 3,000 visitors expected in Montréal to celebrate the 10th anniversary of Dead by...

The world's most profitable horror game, created in Montréal by Behaviour InteractiveMONTREAL, June 12, 2026 /CNW/ - Behaviour Interactive invites members of the media...

VEVOR Launches “Beat the Heat at Home” Summer Comfort Lineup for Outdoor Living

HOUSTON, June 13, 2026 /PRNewswire/ -- As summer temperatures climb, staying cool at home shouldn't require a sky-high electric bill, a cooler full of...

As the Lights Fade, Vivid Sydney 2026 Leaves the City Glowing

Images HERESYDNEY, June 13, 2026 /PRNewswire/ -- Off the back of 23 nights of spectacular sights, events and experiences, Vivid Sydney switches off its...

As the Lights Fade, Vivid Sydney 2026 Leaves the City Glowing

Images HERESYDNEY, June 13, 2026 /PRNewswire/ -- Off the back of 23 nights of spectacular sights, events and experiences, Vivid Sydney switches off its...

As the Lights Fade, Vivid Sydney 2026 Leaves the City Glowing

Images HERESYDNEY, June 13, 2026 /CNW/ -- Off the back of 23 nights of spectacular sights, events and experiences, Vivid Sydney switches off its...

As the Lights Fade, Vivid Sydney 2026 Leaves the City Glowing

Images HERESYDNEY, June 13, 2026 /PRNewswire/ -- Off the back of 23 nights of spectacular sights, events and experiences, Vivid Sydney switches off its...

FREELANDER 8 Makes First Public Appearance Ahead of Official Abu Dhabi Launch

FREELANDER 8 made its first public appearance at the Abu Dhabi Investment Forum held at The Peninsula Shanghai on June 11, 2026.

GOOD WORKS, GIVING, AND GLAMOUR SHINE AT NORTH SHORE ANIMAL LEAGUE AMERICA’S RESCUE GALA CELEBRATING ANIMAL RESCUE AND ADOPTION

Attendees Included Event Chairperson Beth Stern, Event Host Will Ganss, Event Entertainer Joshua Radin, Liz Gillies, The Dogist (Elias Weiss Friedman,) and Others.  Proceeds...

Hexaware Expands Presence in Gujarat with New Delivery Center at GIFT City

MUMBAI, India, LONDON and ISELIN, N.J., June 13, 2026 /PRNewswire/ -- Hexaware Technologies , a global provider of IT solutions and services, today opened a...

Hexaware Expands Presence in Gujarat with New Delivery Center at GIFT City

MUMBAI, India, LONDON and ISELIN, N.J., June 13, 2026 /PRNewswire/ -- Hexaware Technologies , a global provider of IT solutions and services, today opened a...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsDirector

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers